Home > Insider Trading > Filing (0001466049-10-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Biodel Inc	BIOD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1281446	Great Point Partners Llc	165 Mason Street 3Rd Floor Greenwich CT 06830		Yes	No	No	No
1397513	David Kroin	C/O Biodel Inc 100 Saw Mill Road Danbury CT 06810		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2009-12-31	78,890	$5.06	1,161,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2009.
This transaction was executed in multiple trades at prices ranging from $5.00 to 5.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount shown represents the beneficial ownership of the issuer's securities by Great Point Partners I, L.P., which may be deemed attributable to Mr. Kroin because Mr. Kroin is a co-founder and managing director of Great Point Partners I, L.P. Mr. Kroin serves as a director of the issuer as a representative of Great Point Partners I, L.P., and accordingly Great Point Partners I, L.P. may be deemed to be a director by deputization. Mr. Kroin disclaims beneficial ownership of the shares except to the extent of his pecuinary interest therein.